Vimian acquires animal pharmaceuticals company in the UK

VimianacquiresanimalpharmaceuticalscompanyintheUK

Copy link

Today Vimian Group signed an agreement to acquire Bova Holdings Limited (Bova), a leading companion animal health specialty pharmaceuticals company in the United Kingdom.

The company offers customised specialty pharmaceuticals for companion animals.

Established in 2017, Bova offers specialty pharmaceuticals covering a wide and expanding range of product classes. The company has more than 100 specialty pharmaceutical formulations, all raw materials and products are compliant with quality standards set out by regulatory authorities and the pharmaceuticals industry. Bova serves veterinary clinics and hospitals across the UK and in ten additional European markets through an online ordering system with deliveries within 24 hours.

Nick Bova, founder and CEO of Bova, will continue to lead the company as part of Nextmune and Vimian.

Morenews

News

2026-09-24

KEYTO Group establishes home security as a new business vertical

KEYTO Group continues to broaden its home services offering with a new vertical in home security. The first company to be added is the Swedish company Säkra Larm.

News

2026-09-23

Audria expands into the UK with Tandem Property

Audria, a tech-driven real estate-services platform, expands into the UK with the addition of Tandem Property. Tandem Property provides property and asset management solutions, and is the fifth company to join Audria, following Newsec, Novier, Sveaviken and Avy.

News

2026-09-02

Audria strengthens its real estate services offering with the addition of Novier

Audria, which brings together leading real estate services companies with a focus on technology, AI and international growth, strengthens its offering with the addition of Novier.